1. Under what circumstance can an exporter withdraw a batch of drugs from export after being informed by the licensing authority?
2. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
3. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
4. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
5. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
6. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
7. Which type of ophthalmic preparations is allowed to have a preservative?
8. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
9. What is the term of office for members of the Registration Board?
10. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
11. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
12. What substances are NOT included in the definition of "Drug" under Schedule-I?
13. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
14. Which of the following is NOT considered as "Therapeutic goods" under the Act?
15. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
16. What is the penalty for a person who fails to provide information requested by the Authority?
17. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
18. What is the main duty of a Federal Inspector?
19. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
20. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
21. Which power of the Inspector requires specific authorization by the Government?
22. What is the purpose of Schedule-III of the DRAP Act?
23. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
24. What are "Medicated Cosmetics" under Schedule-I?
25. What must be included in the labelling and promotion of a registered drug?
26. What labeling requirements apply to drugs manufactured for experimental purposes?
27. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
28. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
29. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
30. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
31. What does the term "Advertise" mean under Schedule-II?
32. The Drugs Act, 1976 extends to which of the following areas?
33. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
34. When can deviations be made from the information submitted during the registration of a drug?
35. What kind of offense is non-cognizable under the Drugs Act 1976?
36. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
37. The Authority shall levy and collect fees for its functions at rates determined by:
38. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
39. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
40. Which type of research involves intervention, treatment, or medication programs using human subjects?
41. Which of the following is NOT a source of financing the Drug Regulatory Authority Fund?
42. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
43. What type of containers are ophthalmic solutions and suspensions required to be contained in?
44. What is the maximum duration for which the approval of an advertisement under sub-rule (1) is valid?
45. Who shall not be liable for a contravention of Section 23 of the Drugs Act 1976?
46. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
47. What action should the Authority take in response to objections raised by the Auditor-General?
48. Who is considered an "investigator" under the Drugs (Research) Rules?
49. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
50. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
51. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
52. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
53. In which situations may the Registration Board provisionally register a drug for a period of two years?
54. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
55. In which circumstances may the Registration Board register a drug on its own motion?
56. Which of the following criteria should promotional claims about drugs adhere to?
57. What is the purpose of the criteria regarding medical representatives?
58. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
59. Which of the following offenses punishable under Schedule-III is non-cognizable?
60. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
61. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
62. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
63. What is the purpose of the Drugs (Research) Rules, 1978?
64. What is the short title of the rules that govern the Drugs Appellate Board?
65. What is the duration of a license to export drugs?
66. What is the purpose of an "airlock" in pharmaceutical manufacturing?
67. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
68. What is the tenure of the CEO's appointment, and how many times can it be extended?
69. What does the term "Advertise" mean under Schedule-II?
70. What is the purpose of Schedule-III of the DRAP Act?
71. What does an Inspector require from a person during a search or seizure under Schedule-V?
72. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
73. Which of the following statements about advertisement material is NOT true?
74. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
75. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
76. What is the purpose of the Committee on Drugs Evaluation?
77. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
78. What action should the Authority take in response to objections raised by the Auditor-General?
79. What is the penalty for a person who fails to provide information requested by the Authority?
80. What degree qualifications are required for the competent technical staff involved in the manufacture of drugs by way of basic or semi-basic manufacture?
81. What is the meaning of "sponsor" in the context of the Drugs (Research) Rules?
82. In what situations can a drug or substance be advertised to the medical, pharmaceutical, and allied professions without referring to the Federal Government?
83. What is the primary purpose of the Committee of Experts on Drug Research?
84. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
85. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
86. What is the role of the Quality Control Department in the manufacturing process?
87. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
88. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
89. When does an Inspector need to divide a sample into three portoons instead of four?
90. Who is responsible for carrying out the audit of the Authority's accounts?
91. What condition must be met for an application for renewal of a licence to be entertained?
92. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
93. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
94. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
95. Within what time frame should the Authority submit its annual report to the Federal Government?
96. What is the purpose of an "airlock" in pharmaceutical manufacturing?
97. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
98. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
99. According to the schedule in the Drugs (Specifications) Rules, what specifications should drugs bear that reference publications specified under sub-clause (ii) of clause (z) of Section 3?
100. Which of the following offenses punishable under Schedule-III is non-cognizable?
